Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Drug Injection Surveillance and Care Enhancement for Rural Northern New England (UH3)

NCT05466331 is registered in ClinicalTrials.gov with Baystate Medical Center as lead sponsor.

NCT NCT05466331
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05466331 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Drug Injection Surveillance and Care Enhancement for Rural Northern New England (UH3)
Lead sponsor
Baystate Medical Center
Phase
Not applicable
Overall status
Unknown status
Start date
May 18, 2022
Completion date
July 31, 2024
Enrollment
220 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c, iv drug usage, opioid use disorder